Literature DB >> 19553823

Does extended lymphadenectomy preclude laparoscopic or robot-assisted radical cystectomy in advanced bladder cancer?

Martin C Schumacher1, Martin N Jonsson, N Peter Wiklund.   

Abstract

PURPOSE OF REVIEW: Open radical cystectomy with an appropriate bilateral lymph node dissection (LND) is currently the standard treatment for patients with muscle-invasive bladder cancer. Approximately 25% of patients with stages T1-T4 N0 M0 harbour metastatic lymph nodes at the time of radical cystectomy. Results from open high volume radical cystectomy series suggest that a more extended LND provides the best survival outcomes and the lowest local recurrence rates. Currently, there is controversy whether laparoscopic or robot-assisted extended LND at radical cystectomy is technically feasible and whether it can provide oncological control equivalent to open LND series at the time of radical cystectomy. RECENT
FINDINGS: Laparoscopic LND is technically demanding and requires prolonged operation time. Most studies to date indicate that fewer nodes are removed than with an open approach, putting a question mark to this surgical approach from an oncological point of view. Limited data on lymph node yield using a robot-assisted approach are available; however, several series found similar results as in open series.
SUMMARY: At present, there is no conclusive evidence showing that laparoscopic LND gives similar results than open LND. Robot-assisted LND is still in its learning curve and more patient series are needed.

Entities:  

Mesh:

Year:  2009        PMID: 19553823     DOI: 10.1097/MOU.0b013e32832eb386

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  3 in total

Review 1.  [Lymphadenectomy for bladder cancer: current status and controversies].

Authors:  T Metzger; G N Thalmann; P Zehnder
Journal:  Urologe A       Date:  2012-03       Impact factor: 0.639

2.  Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial.

Authors:  Bernard H Bochner; Guido Dalbagni; Daniel D Sjoberg; Jonathan Silberstein; Gal E Keren Paz; S Machele Donat; Jonathan A Coleman; Sheila Mathew; Andrew Vickers; Geoffrey C Schnorr; Michael A Feuerstein; Bruce Rapkin; Raul O Parra; Harry W Herr; Vincent P Laudone
Journal:  Eur Urol       Date:  2014-12-08       Impact factor: 20.096

3.  Pelvic lymphadenectomy in the treatment of invasive bladder cancer: literature review.

Authors:  Ehab A Elzayat; Ali A Al-Zahrani
Journal:  Adv Urol       Date:  2011-08-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.